Osteopathia striata

From WikiMD's WELLNESSPEDIA


Osteopathia striata
Synonyms Voorhoeve disease
Pronounce N/A
Specialty N/A
Symptoms Linear striations in long bones, pelvis, scapulae
Complications None typically associated
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Radiographic imaging
Differential diagnosis Osteopathia striata with cranial sclerosis, Melorheostosis, Osteopoikilosis
Prevention N/A
Treatment Symptomatic treatment
Medication N/A
Prognosis Generally benign
Frequency Rare
Deaths N/A


Osteopathia striata is a rare condition characterized by linear striations in the long bones and pelvis visible on x-ray. The condition is often associated with cranial sclerosis, a condition that leads to abnormal hardening of the skull bones.

Symptoms[edit]

The symptoms of osteopathia striata can vary greatly from person to person. Some individuals may have no symptoms at all, while others may experience:

Causes[edit]

Osteopathia striata is caused by mutations in the AMER1 gene. This gene provides instructions for making a protein that is involved in the regulation of a signaling pathway known as the Wnt pathway. The Wnt pathway plays a critical role in the formation and development of bones and other tissues.

Diagnosis[edit]

Diagnosis of osteopathia striata is typically made through a combination of clinical examination and imaging studies. X-rays are often used to identify the characteristic linear striations in the bones. Genetic testing may also be performed to confirm the diagnosis.

Treatment[edit]

There is currently no cure for osteopathia striata. Treatment is focused on managing the symptoms and preventing complications. This may include:

Prognosis[edit]

The prognosis for individuals with osteopathia striata varies depending on the severity of the symptoms. Some individuals may have a normal lifespan with few complications, while others may experience significant disability and health problems.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.